Skip to main content

Novel small molecule activators of the NLRP3 inflammasome as immunostimulants

Objective

We have identified a novel family of potent small molecule activators of the NLRP3 inflammasome. The goal of this project is to determine the feasibility of developing these new immunostimulators into an attractive commercial proposition. Establishment of technical feasibility will involve identification the most promising modifications of our drug candidates and testing their efficacy in disease models of cancer and immunization. In addition, we will determine commercial feasibility by conducting market research and competition analysis and by engaging potential industry partners.

Host institution

UNIVERSITAETSKLINIKUM FREIBURG
Net EU contribution
€ 150 000,00
Address
Hugstetter Strasse 49
79106 Freiburg
Germany

See on map

Region
Baden-Württemberg Freiburg Freiburg im Breisgau, Stadtkreis
Activity type
Higher or Secondary Education Establishments
Other funding
No data

Beneficiaries (1)

UNIVERSITAETSKLINIKUM FREIBURG
Germany
Net EU contribution
€ 150 000,00
Address
Hugstetter Strasse 49
79106 Freiburg

See on map

Region
Baden-Württemberg Freiburg Freiburg im Breisgau, Stadtkreis
Activity type
Higher or Secondary Education Establishments
Other funding
No data